Oasis Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 17-06-2024
- Paid Up Capital ₹ 3.84 Cr
as on 17-06-2024
- Company Age 30 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 7.40 M
as on 17-06-2024
- Revenue %
(FY 2023)
- Profit -101.23%
(FY 2023)
- Ebitda 34.30%
(FY 2023)
- Net Worth -12.39%
(FY 2023)
- Total Assets -22.16%
(FY 2023)
About Oasis Pharmaceuticals
The Corporate was formerly known as Oasis Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 3.84 Cr.
The company has closed loans amounting to ₹7.40 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Avinash Lohia, Adarsh Lohia, and Alok Narain serve as directors at the Company.
- CIN/LLPIN
U74899DL1994PLC057156
- Company No.
057156
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
31 Jan 1994
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Oasis Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alok Narain  | Director | 31-Jan-1994 | Current |
| Avinash Lohia | Director | 24-Apr-2017 | Current |
| Adarsh Lohia | Director | 23-Mar-2015 | Current |
Financial Performance of Oasis Pharmaceuticals.
Oasis Pharmaceuticals Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 101.23% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oasis Pharmaceuticals?
In 2023, Oasis Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vishwa Micro Processors Pvt. Ltd.Active 38 years 5 monthsAvinash Lohia and Adarsh Lohia are mutual person
- Chowdhury Roller Flour Mills Pvt LtdActive 37 years 6 days
Avinash Lohia and Adarsh Lohia are mutual person
- Shiv Shakti Tubes And Industries LimitedActive 37 years 10 months
Avinash Lohia and Adarsh Lohia are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 08 Oct 1997 | ₹2.40 M | Satisfied |
Indian Overseas Bank Creation Date: 08 Oct 1997 | ₹5.00 M | Satisfied |
How Many Employees Work at Oasis Pharmaceuticals?
Oasis Pharmaceuticals has a workforce of 1 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oasis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oasis Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
